SPECT/CT Radiomics for Differentiating between Enchondroma and Grade I Chondrosarcoma
Tomography · 2023
DOI: 10.3390/tomography9050148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tomography, 2023. Verfasst von Hyukjin Yoon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine, Department of Radiology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Re…. Hauptthemen laut MEDLINE: Bone Neoplasms, Chondrosarcoma, Chondroma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Information & Communications Technology Planning & Evaluation.
Abstract (Originalsprache)
This study was performed to assess the value of SPECT/CT radiomics parameters in differentiating enchondroma and atypical cartilaginous tumors (ACTs) located in the long bones. Quantitative HDP SPECT/CT data of 49 patients with enchondromas or ACTs in the long bones were retrospectively reviewed. Patients were randomly split into training (n = 32) and test (n = 17) data, and SPECT/CT radiomics parameters were extracted. In training data, LASSO was employed for feature reduction. Selected parameters were compared with classic quantitative parameters for the prediction of diagnosis. Significant parameters from training data were again tested in the test data. A total of 12 (37.5%) and 6 (35.2%) patients were diagnosed as ACTs in training and test data, respectively. LASSO regression selected two radiomics features, zone-length non-uniformity for zone (ZLNUGLZLM) and coarseness for neighborhood grey-level difference (CoarsenessNGLDM). Multivariate analysis revealed higher ZLNUGLZLM as the only significant independent factor for the prediction of ACTs, with sensitivity and specificity of 85.0% and 58.3%, respectively, with a cut-off value of 191.26. In test data, higher ZLNUGLZLM was again associated with the diagnosis of ACTs, with sensitivity and specificity of 83.3% and 90.9%, respectively. HDP SPECT/CT radiomics may provide added value for differentiating between enchondromas and ACTs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nuclear Medicine, Department of Radiology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Orthopedic Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Division of Nuclear Medicine, Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Division of Nuclear Medicine, Department of Radiology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
ORCID-Profile: Hyukjin Yoon, Woo Hee Choi, Min Wook Joo, Yong-An Chung
Förderung
- Institute of Information & Communications Technology Planning & Evaluation
Zitieren
APA
Yoon, H., Choi, W. H., Joo, M. W., Ha, S., & Chung, Y. A. (2023). SPECT/CT Radiomics for Differentiating between Enchondroma and Grade I Chondrosarcoma. Tomography. https://doi.org/10.3390/tomography9050148
Vancouver
Yoon H, Choi WH, Joo MW, Ha S, Chung YA. SPECT/CT Radiomics for Differentiating between Enchondroma and Grade I Chondrosarcoma. Tomography. 2023. doi:10.3390/tomography9050148
BibTeX
@article{Yoon2023,
author = {Yoon, Hyukjin and Choi, Woo Hee and Joo, Min Wook and Ha, Seunggyun and Chung, Yong-An},
title = {SPECT/CT Radiomics for Differentiating between Enchondroma and Grade I Chondrosarcoma},
journal = {Tomography},
year = {2023},
doi = {10.3390/tomography9050148}
}
EUVIMED